A Gallacher

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Sandra Navarra, Renato Guzmán, A Gallacher et al. · The Lancet · 2011 · 2K citations

Medicine, Immunology, Pharmacology +11

Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus

DJ Wallace, Sandra Navarra, M. Pétri et al. · Lupus · 2012 · 120 citations

Medicine, Pharmacology, Pharmacotherapy +13

Efficacy and Tolerability Profile of Etoricoxib in Patients with Osteoarthritis: A Randomized, Double-blind, Placebo and Active-comparator Controlled 12-Week Efficacy Trial

Albert Leung, Kerstin Malmström, A Gallacher et al. · Current Medical Research and Opinion · 2002 · 118 citations

Medicine, Pharmacology, Pharmacotherapy +16

Urate crystal-induced chemotactic factor: isolation and partial characterization.

I Spilbert, A Gallacher, J M Mehta et al. · Journal of Clinical Investigation · 1976 · 65 citations · Full text

Life Sciences, Cell Biology, Immunology +11

Studies on crystal-induced chemotactic factor. II. Role of phagocytosis.

Isaias Spilberg, A Gallacher, B Mendell · PubMed · 1975 · 20 citations

Life Sciences, Cell Biology, Immunology +9